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Introduction: Paired cohort investigations assessing the evolution of anthropometric
indices are scarce. Here we assessed the 10-year evolution of BMI, total body fat, and
lean body mass in 50,019 participants aged 18–90 years at the time of first assessment.
Material and Methods: A retrospective cohort study using an electronic database
that contains anonymized, longitudinal data from Primary Care medical records covering
the 2007–2008 and 2017–2018 periods. Total body fat was estimated using the Clínica
Universidad de Navarra-Body Adiposity Estimator formula, and the Hume formula was
applied to estimate lean body mass.
Results: The mean BMI of participants <60 years old in the 2007–2008 period
increased significantly, from 27.5 to 28.3 kg/m2 (p < 0.001). However, the BMI of older
subjects decreased during the next decade, from 28.9 to 28.3 kg/m2 (p < 0.001). The
estimated total body fat showed a continuous progressive increase over all ages. Finally,
lean body mass showed a progressive increase until the 40s, with a plateau between
40–45 years old and an uninterrupted decrease until older ages. Also, subjects who
increased their BMI by 2 kg/m2 during the 10-year period were mainly women and
younger at baseline, with a lower initial BMI and total body fat in comparison with those
who experienced a BMI decrease of ≥2.0 kg/m2.
Conclusion: The evolutions of BMI and the estimated body compositions reported
here confirm that the adverse decrease in lean body mass begins in middle age.
The proportion of older subjects is important when evaluating overweight and obesity
prevalence in cross-sectional studies.
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INTRODUCTION
The prevalence of individuals who are overweight or obese
has rapidly increased during the last three decades in many
developed and developing countries (1, 2). Therefore, excess
body weight has become a major public health concern
worldwide, with enormous physical, social, economic, and
psychological repercussions (3, 4). Demographic surveys also
assume that body mass index (BMI) increases at the same
rate among all subjects, with a distribution that remains
constant across time. However, a rightward shift in the BMI
distribution has been described, with those who are obese
shifting to even higher BMI levels (5, 6). Another concern is
the detection of higher waist circumference at each BMI level,
further accelerating the cardiometabolic health consequences of
abdominal adiposity (7). Nevertheless, the definition of obesity
using BMI classification is far from perfect, as it fails to provide
an accurate measure of the amount and distribution of body
fat (8, 9). For this reason, when gold standard measurements,
such as dual-energy X-ray absorptiometry or magnetic resonance
imaging, are not available, anthropometric indices that combine
traditional measurements have been developed to estimate
total body fat and abdominal adiposity (10, 11). Similarly,
multiple indices to estimate lean body mass have also been
developed (12).
The descriptions of the rise in average BMI or prevalence
of excess weight over time are mainly based on nationally
representative, repeated, cross-sectional household surveys (13,
14). These studies use to collect data from different individuals
drawn from the same population at successive points in time and
are used for the aggregate analysis of change over time (15, 16).
Therefore, these data cannot be used to detect weight changes
within the same individual. On the other hand, longitudinal
studies involve information directly gathered in a survey of
households or individuals and follow individual persons over
time. Longitudinal studies allow researchers to separate the
independent effects of age, period, and cohort from trends in
overweight and obesity rates (17). However, large paired cohort
investigations assessing anthropometric indices between long
periods are scarce. Furthermore, being able to understand who
will become obese has direct implications in the quest for
adequate public health interventions: for example, to determine
whether high-risk individuals or the whole population should
be targeted.
To delve further into anthropometric dynamics, we designed
the present study to evaluate the 10-year evolution of BMI
and estimated total body fat and lean body mass in the same
50,019 participants aged 18–90 years old at the time of the
first assessment.
MATERIALS AND METHODS
Ethics Approval
The study was approved by the Ethics Committee of the Primary
Health Care University Research Institute (IDIAP) Jordi Gol
(code 19/017-P). All patient records and information were
anonymized and de-identified prior to analysis.
Study Design and Data Source
This was a retrospective, cohort study using an electronic
database that contains anonymized, longitudinal data on clinical
history from Primary Care medical records. The database has
information from the 29 primary care centers pertaining to the
Catalan Health Institute in the province of Lleida, Spain, which
serves ∼400,000 subjects (80% of the total population). All data
were obtained through specific software (the Electronic Clinical
station in Primary Care; eCAP) developed by the institution and
used since 2001.
Data for the first assessment was obtained covering the period
between January 2007 and December 2008. Participants with
missing information on height or weight, younger than 18 years
and older than 90 years, and those with outlying values for BMI
(BMI < 15 or BMI > 50) were excluded from our analyses.
From this initial cohort, we selected those alive and with a second
measurement of their BMI between January 2017 and June 2018.
After these exclusions, data from 50,019 subjects who have a 10-
years paired BMI were used to study longitudinal anthropometric
indices dynamic. Main data of the study population is displayed
inTable 1. No deaths occurred among the participants during the
study period.
The age of the individuals was stratified into the following
groups: 18–29 years (only in the 2007–2008 period), 30–39, 40–
49, 50–59, 60–79, 80–90, and 90–100 years (only in the 2017–
2019 period). Data were also evaluated according to the definition
of the elderly proposed by the United Nations, and the cut-off of
60 years was used to refer to the older or elderly persons (17).
Assessment of Anthropometric Indices
Data for patients were extracted for each year, and the most
recent values were chosen. Weight (kilograms) at each respective
age and height (meters) at baseline were used to calculate
anthropometric indices. Normal weight was defined as a BMI
between 18.5 and 24.9 kg/m2, overweight when BMI was between
25.0 and 30.0 kg/m2, and obesity when BMI was higher than 30.0
kg/m2 (18). Additionally, within the obesity range, a distinction
was made between type I (BMI between 30.0 and 34.9 kg/m2),
type 2 (BMI between 35.0 and 39.9 kg/m2), and morbid (BMI >
40 kg/m2) obesity. We calculated BMI change between the 2007–
2008 and 2017–2018 periods and subjects who lost ≥2.0 kg/m2
and those who gained ≥2.0 kg/m2 were identified.
Total body fat was estimated using the Clínica Universidad
de Navarra - Body Adiposity Estimator (CUN-BAE) formula:
TABLE 1 | Characteristics of the participants in the study in the 2007–2008 and
2017–2018 paired periods.
2007–2008 2017–2018
Total population included in the database 376,920 400,439
Population selected for the study 50,019 50,019
Women, n (%) 28,819 (57.6) 28,819 (57.6)
Age (years) 56.3 ± 15.7 66.8 ± 14.3
Type 2 diabetes, n (%) 1.650 (3.3) 3.451 (6.9)
Hypertension, n (%) 5.202 (10.4) 9.403 (18.8)
Pregnant women, n (%) 8,763 (2.3) 6,820 (1.7)
Subjects underwent bariatric surgery, n (%) 0 (0) 328 (0.6)
Frontiers in Endocrinology | www.frontiersin.org 2 April 2020 | Volume 11 | Article 209
Santos et al. Anthropometric Indices After a Follow-Up
FIGURE 1 | Mean BMI distribution of the 50,019 subjects in the 2007–2008 (solid line) and 2017–2018 (dashed line) paired periods according to their age at the
first evaluation.
−44.988 + (0.503 × age) + (10.689 × sex) + (3.172 × BMI) –
(0.026 × BMI2) + (0.181 × BMI × sex) – (0.02 × BMI × age)
– (0.005 × BMI2 × sex) + (0.00021 × BMI2 × age), where male
= 0 and female = 1 for sex, and age in years (11, 18). Finally, to
estimate lean body mass the Hume formula was applied: 0.32810
× weight (kg) + 0.33929 × height (cm) – 29.5336 (for males),
and 0.29569 × weight (kg) + 0.41813 × height (cm) – 43.2933
(for females) (12, 19).
Statistical Analysis
Statistical analyses were performed using the SPSS software (IBM
SPSS Statistics for Windows, Version 20.0. Armonk, NY, USA).
A normal distribution of the variables was established using the
Kolmogorov-Smirnov test, and data are expressed as the mean±
SD, median (range), or as a percentage. A paired Student’s t-test
was used to compare the baseline data (period 2007–2008) with
those obtained at the end of follow-up (period 2017–2018), while
categorical variables were compared using the χ2 test. All “p”
values were based on a two-sided test of statistical significance.
Significance was accepted at a level of p < 0.05.
RESULTS
In both periods (2007–2008 and 2017–2018), the mean BMI
distribution across different ages followed the same pattern: a
progressive increase until the age of 60 years, and thereafter
begins to diminish until older ages (Figure 1, Table 2). In
addition, BMI was lower in younger than in elderly individuals,
both in the 2007–2008 period [27.5 (15.0–49.9) vs. 29.0
(15.1–49.9) kg/m2, p< 0.001) and 2017–2018 period [27.7 (15.1–
50.0) vs. 28.5 (15.0–57.3) kg/m2, p < 0.001] (Table 3).
When the effect of the 10-year evolution was assessed, the
mean BMI of participants younger than 60 years in the 2007–
2008 period experienced a significative increase, from 27.5 (15.6–
49.9) to 28.3 (15.1–58.0) kg/m2 (p < 0.001) (Figure 1, Table 2).
However, older subjects showed a reduction in their BMI during
the next decade, decreasing from 28.9 (15.1–49.9) to 28.3 (15.0–
55.2) kg/m2 (p < 0.001). In the same way, the 32.5% prevalence
in obesity (BMI ≥ 30 kg/m2) in younger subjects increased to
38.1% after 10 years, whereas the percentage decreased from
40.4 to 35.9% (p < 0.001) among the elderly group. When
a gender-specific analysis was performed, similar results were
obtained (Table 3).
Different trajectories in BMI during the 10-year period were
identified. Only 12.2% of the participants maintained a normal
BMI throughout the entire study period. From the 10,041
participants who had a normal BMI at baseline, 3012 (30.0%)
became overweight, 293 (2.9%) became class I obese, and 22
(0.2%) became class II obese, while the remaining eight achieved
a BMI ≥ 40 kg/m2.
In addition, from the population younger than 60 years in
the 2007–2008 period, we identified 15,877 participants who
increased their BMI ≥ 2.0 kg/m2 during the 10-year follow-
up, whereas 10,403 participants experienced no change or a
decrease in their BMI. Subjects who increased their weight
showed a higher prevalence of women (59.5 vs. 55.0%, p <
0.001), were younger at baseline [45.0 (18.0–59.0) vs. 48.0
(18.0–59.0) years, p < 0.001], and exhibited a lower initial
BMI [26.9 (15.0–49.6) vs. 28.6 (15.5–49.9) kg/m2, p < 0.001],
together with a lower percentage of total body fat [33.4% (3.9–
57.1) vs. 35.1% (8.3–57.3), p < 0.001] relative to those who
experienced a BMI decrease of 2.0 kg/m2 or more during
the same period.
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TABLE 2 | Evolution of mean body mass index and estimated total body fat and lean body mass by intervals of 10 years from 18 to 100 years in both periods of time
(2007–2008 and 2017–2018).
n BMI (kg/m2) Estimated total body fat (%) n Estimated lean body mass (%)
18 years in 2007–2008 154 22.0 (15.5–39.0) 25.5 (5.6–48.6) 133 36.7 (27.5–50.2)
18 years in 2017–2018 – – – – –
30 years in 2007–2008 449 25.8 (16.3–45.7) 32.1 (11.5–54.9) 346 38.9 (28.0–59.9)
30 years in 2017–2018 194 26.1 (17.9–51.6) 33.6 (10.4–57.0) 168 38.0 (25.8–57.2)
40 years in 2007–2008 574 27.1 (16.2–48.4) 32.8 (12.2–56.4) 399 40.6 (24.9–54.4)
40 years in 2017–2018 449 27.0 (15.1–48.4) 34.6 (7.0–56.4) 346 39.5 (29.5–61.2)
50 years in 2007–2008 883 28.3 (15.5–49.8) 34.9 (13.0–57.2) 565 41.0 (25.3–55.4)
50 years in 2017–2018 574 28.2 (17.5–49.4) 35.1 (14.5–57.2) 399 40.8 (26.3–58.8)
60 years in 2007–2008 1,255 29.0 (18.5–49.8) 38.1 (17.1–56.2) 738 39.1 (26.2–58.3)
60 years in 2017–2018 883 29.0 (17.9–55.1) 36.8 (17.1–57.6) 565 41.1 (25.2–55.7)
70 years in 2007–2008 1,033 29.1 (15.1–49.4) 39.9 (20.1–57.6) 613 38.6 (25.6–58.1)
70 years in 2017–2018 1,255 29.0 (18.1–56.6) 39.1 (20.0–59.2) 738 39.2 (25.0–54.5)
80 year in 2007–2008 537 28.4 (18.7–49.5) 41.8 (21.5–57.9) 341 35.2 (20.3–50.3)
80 years in 2017–2018 1,033 28.4 (16.3–55.2) 40.1 (18.4–59.4) 613 38.1 (23.1–60.1)
90 years in 2007–2008 14 25.7 (20.4–31.2) 42.6 (27.7–47.6) 12 32.3 (28.1–39.9)
90 years in 2017–2018 537 26.7 (16.1–41.1) 41.9 (20.6–54.3) 341 34.3 (19.4–50.9)
100 years in 2007–2008 – – – –
100 years in 2017–2018 14 24.3 (18.8–33.1) 41.6 (26.7–49.8) 12 32.0 (27.2–38.5)
Data are expressed as mean (range). Total body fat was estimated using the Clínica Universidad de Navarra—Body Adiposity Estimator (CUN-BAE) formula. Lean body mass was
estimated using the Hume formula.
TABLE 3 | Ten-year evolution of the mean BMI and BMI categories in those participants younger and older than 60 years at the first evaluation.
2007–2008 2017–2018
n Median (range) Median (range) p
Evolution of mean BMI (kg/m2)
<60 years at 2007–2008 All 26,280 27.5 (15.0–49.9) 28.3 (15.1–58.0) <0.001
Men 11,100 28.5 (15.1–49.6) 28.7 (15.1–58.0) <0.001
Women 15,180 26.9 (15.0–49.9) 27.9 (15.2–57.3) <0.001
≥60 years at 2007–2008 All 23,740 29.0 (15.1–49.9) 28.3 (15.0–56.8) <0.001
Men 10,101 28.6 (16.5–49.8) 28.1 (16.1–49.3) <0.001
Women 13,639 29.3 (15.1–49.9) 28.5 (15.0–56.6) <0.001
2007–2008 2017–2018
n% n% p
Evolution of BMI classification
<60 years at 2007–2008 Underweight 977 (3.7) 762 (2.9) <0.001
Normal weight 6,787 (25.8) 5,799 (22.1) <0.001
Overweight 9,978 (38.0) 9,711 (37.0) <0.001
Obesity I 5,780 (22.0) 6,406 (24.4) <0.001
Obesity II 2,031 (7.7) 2,552 (9.7) <0.001
BMI > 40 727 (2.8) 1,049 (4.0) <0.001
≥60 years at 2007–2008 Underweight 133 (0.6) 359 (1.5) <0.001
Normal weight 3,254 (13.7) 4,407 (18.6) <0.001
Overweight 10,770 (45.4) 10,556 (44.5) <0.001
Obesity I 7,060 (29.7) 6,158 (25.9) <0.001
Obesity II 1,964 (8.3 1,780 (7.5) <0.001
BMI > 40 559 (2.4) 480 (2.0) <0.001
The evolution of the estimated total body fat across different
ages in both periods of time (2007–2008 and 2017–2018) is
represented in Figure 2. There is a continuous progressive
increase, which is faster in younger than in older ages, and that
achieves the highest values in the elderly. Globally, total body
fat was lower in those younger than 60 years in comparison
to older individuals, both in the 2007–2008 period [34.1%
(3.9–57.3) vs. 39.6% (15.3–58.0); p < 0.001] and 2017–2018
period [36.3% (7.0–59.2) to 40.0% (16.9–59.4), p < 0.001]
(Table 4).
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FIGURE 2 | Estimated mean total body fat distribution of the 50,019 subjects in the 2007–2008 (solid line) and 2017–2018 (dashed line) paired periods according to
their age at the first evlaution.
When the effect of the 10-year evolution was assessed in those
younger than 60 years, total body fat experienced a significant
increase between the 2007–2008 and 2017–2018 periods [34.1%
(3.9–57.3) vs. 36.3% (7.0–59.2); p < 0.001)]. In those aged
60 years and older, total body fat increased with a lesser
intensity; from 39.6% (15.3–58.0) to 40.0% (16.9–59.4) (p <
0.001) (Figure 2, Table 4).
Finally, estimated lean body mass showed a dissimilar
trajectory compared to BMI and total body fat: from 18 years
old to the 40s, lean body mass increased progressively, showed
a plateau between 40 and 45 years old, and thereafter began
an uninterrupted decrease until older ages (Figure 3, Table 4).
Nevertheless, considering the barrier of 60 years, lean body mass
was slightly higher among the younger participants in both
periods of time: 39.7% (20.1–77.8) vs. 38.2% (20.3–73.2) in the
2007–2008 period, and 40.1% (21.5–80.7) vs. 37.8% (19.4–79.3)
(p < 0.001 in both cases). When the impact of 10 years addition
was assessed, lean body mass experienced a significant increase
before the age of 60 years, decreasing afterward. The same
dynamics were observed when data were evaluated according
to gender.
DISCUSSION
The results of the present study describe the different
evolutions of BMI and the estimated body compositions
(total body fat and lean body mass) across a wide range
of ages, between 18 and 90 years. Our data confirm the
potential adverse decrease in lean body mass beginning in
middle age, and the importance of considering the percentage
of older subjects included in large cross-sectional studies
evaluating overweight and obesity prevalence. In addition, the
discouraging change of the three measurements (BMI, total
body fat, and lean body mass) after a 10-year period is
also provided.
The United Nations uses 60 years old to divide younger and
older cohorts of a population (20). This is not a perfect definition
of an elderly individual, as this notion has different meanings
in different societies and does not accommodate influences
such as chronology, transformation in social role, and change
of competences. However, our data demonstrate an increase
in BMI of seven units from 18 to 60 years that is followed
by a transient plateau in the sixth decade of life, and a new
3.5 BMI units decrease from 70 to 90 years old. These results
are also in concordance with data extracted from a systematic
review and meta-analysis of epidemiological studies, carried out
in 199 countries over three decades between 1980 and 2008
(21). This study showed that the average rate of BMI increase
per decade in men was 0.4 and 0.5 kg/m2 in women (21).
More interesting, when Dobson et al. analyzed seven cross-
sectional health surveys conducted between 1995 and 2017–18
in Australia, prevalence of obesity increased steadily with birth
age until the 1960s and then accelerated (16). In addition, the
12.6% increase in total body fat from 18 to 60 years is followed
by a further 4.5% increase from 60 to 90 years old. Finally,
lean body mass achieves its maximum percentage in a person’s
50s and shows a global decrease of 8.7% from 50 to 90 years
old. Altogether, our results pave the way for the transition from
overweight to presarcopenia in the older population from Lleida,
Spain (22).
The clinical definition of sarcopenia is not broadly accepted.
However, there is a consensus that sarcopenia is a syndrome
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TABLE 4 | Ten-year evolution of the estimated mean total body fat and lean body mass in those participants younger and older than 60 years at the first evaluation.
2007–2008 2017–2018
n Median (range) Median (range) p
Evolution of mean total body fat (%)
<60 years at 2007–2008 All 26,280 34.1 (3.9–57.3) 36.3 (7.0–59.2) <0.001
Men 11,100 29.0 (3.9–49.5) 30.6 (7.0–53.3) <0.001
Women 15,180 38.7 (13.9–57.3) 41.2 (16.8–59.2) <0.001
≥60 years at 2007–2008 All 23,740 39.6 (15.3–58.0) 40.0 (16.9–59.4) <0.001
Men 10,101 31.7 (15.3–50.3) 32.1 (16.9–50.2) <0.001
Women 13,639 44.2 (26.6–58.0) 44.4 (28.1–59.4) <0.001
Evolution of lean body mass (%)*
<60 years at 2007–2008 All 17,910 39.7 (20.1–77.8) 40.1 (21.5–80.7) <0.001
Men 7,506 44.9 (28.3–77.8) 45.1 (28.9–80.7) <0.001
Women 10,404 36.2 (20.1–55.0) 36.9 (21.5–53.7) <0.001
≥60 years at 2007–2008 All 14,140 38.2 (20.3–73.2) 37.8 (19.4–79.3) <0.001
Men 6,218 42.8 (29.7–73.2) 42.5 (28.6–79.3) <0.001
Women 7,922 34.7 (20.3–71.5) 34.3 (19.4–70.2) <0.001
*The estimation of lean body mass was only available in 30,050 subjects.
FIGURE 3 | Estimated mean lean body mass distribution of 32,050 subjects in the 2007–2008 (solid line) and 2017–2018 (dashed line) paired periods according to
their age at the first evaluation and sex.
characterized by the progressive and generalized age-related
loss of skeletal muscle mass associated with low skeletal
muscle strength or low physical performance (23). Sarcopenia
is associated with an increased risk of physical disability, frailty,
poor quality of life, and death (24, 25). In addition, the
International Working Group on Sarcopenia also considers that
muscle mass loss might be present alone or in conjunction with
increased fat mass (26). In our study, we failed to evaluate muscle
function by handgrip or walking speed. However, the European
Working Group on Sarcopenia in Older People also suggests a
“presarcopenia” stage characterized only by low muscle mass
without impact on muscle strength or physical performance
(22). However, and more recently, the same society considers
sarcopenia as a muscle disease associated with aging and older
people which development begins earlier in life, with low muscle
strength overtaking the role of low muscle mass as a principal
determinant (27). In addition, simple measurements and specific
cut-off points that identify and characterize this condition are
recommended. Although we have not measured lean body mass
with accurate techniques, our data indicate that the age of 60 can
be used as a cut-off age to initiate measures to identify subjects
more vulnerable to developing sarcopenia and to prevent or
postpone, as much as possible, onset among the elderly. Similarly,
our data also reinforce the importance to boost muscle in youth
and young adulthood, to preserve muscle in middle age and
minimize deficiency in older age (27). In fact, its prevalence is
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reported to be 5–13% in 60–70-year-olds, increasing to 11–50%
among the population older than 80 years (25). In addition, the
continuous rise of estimated total body fat might also interact
with fat infiltration into muscle, contributing to decrease muscle
quality and work performance (25). In this way, a bidirectional
and synergistically impairment between loss of muscle mass and
obesity might exist (28, 29).
Data from the cross-sectional Study on Nutrition and
Cardiovascular Risk in Spain (ENRICA) reported a general
prevalence of overweight of 39.4% as well as a prevalence of
obesity of 22.9% (30). This study was carried out between June
2008 and October 2010 in 12,883 persons representative of
the non-institutionalized population aged 18 years and older.
Data from the well representative cohort in the province of
Lleida, from 18 to 90 years old, shows that in a similar period
(2007–2008), the prevalence of overweight and obesity were
41.7 and 36.2%, respectively. Differences between these studies
are evident, especially in the obesity stage, and can be partially
explained by the broad range of older people included in our
study: whereas the ENRICA study included 2,438 subjects aged
65 years or older, the present study analyzed data from 23,740
participants between 60 and 90 years old (30). Older subjects
exhibit a higher BMI than younger individuals, and BMI in the
elderly is closer to obesity than to the normal weight stage. This
fact also enhances the importance of including all age ranges
to better estimate obesity prevalence in the general population.
In this way, the cut-off of 60 years old is also important when
evaluating the dynamic evolution of BMI across different periods
of time. For example, the evolution of obesity prevalence between
2007–2008 and 2017–2018 in the entire population in Lleida did
not change: 36.8 and 36.2%, respectively. However, the same
measurement experienced a 5.6% increase among subjects aged
18–60 years old in the 2007–2008 period during the next 10 years
of follow-up, whereas the prevalence of obesity decreased 4.5% in
elderly individuals.
Another focus of interest remains in the ability to identify
subjects at risk of gaining weight over time. More vulnerable
population segments comprise children, low-income individuals,
racial/ethnic minority groups, low educational level, rural
populations, and adults aged >65 years (31, 32). In our 10-
year paired cohort study, we have shown that preventive healthy
public strategies must be focused and intensified in younger
women with lower BMI. Therefore, our data support the notion
that preventive strategies to enhance weight maintenance should
be initiated and implemented at earlier ages.
Some potential limitations should be considered in evaluating
the results of our study. First, we ignore which proportion
of weight and height were self-reported by the participant
or performed under standardized conditions by experienced
health professionals, which makes misclassification possible,
particularly among subjects with obesity. Second, other relevant
information that could influence obesity prevalence and
dynamics, such as socioeconomic status, educational level,
dietary mistakes, behavioral gaps, or lack of physical activity, was
not available in our study. We also did not exclude pregnant
women or subjects who underwent bariatric surgery, despite
their confounding impact on weight and waist circumference.
However, our data represent a large proportion of our
community, including many participants of both genders across
all age frames. Third, the relationship between BMI and
body composition has been estimated in our study. Direct
assessment of body adiposity can be achieved using dual-
energy X-ray absorptiometry or magnetic resonance imaging
(33, 34). Nevertheless, the cost, complexity, and time-consuming
nature of these well-established approaches, together with the
retrospective analyses of the data, limit their application in this
project. Fourth, because these data are gathered from medical
records, they might be biased toward less healthy individuals.
In conclusion, we used data from 50,019 individuals to
describe BMI distribution between the ages of 18 and 90
years, and BMI evolution during the following 10 years in
the same cohort. In addition, total body fat and lean body
mass were also estimated, which contributes data that helps
to understand weight dynamics in the general population. Our
data highlights the importance of considering the cut-off of
60 years when evaluating overweight and obesity prevalence
in large cross-sectional studies. Finally, the discouraging trends
in the three measurements (BMI, total body fat, and lean
body mass) after a 10-year period should focus attention on
reinforcing preventive strategies among younger subjects before
they become overweight.
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